Table 2 Demographic and clinical data during ICU admission.

From: Prevalence of post-intensive care syndrome in mechanically ventilated patients with COVID-19

 

N = 186

Sex, male n (%)

126 (68)

Age, mean (SD), years

59 (12)

BMI prior to ICU admission, mean (SD)

31 (5)

Ethnicity

Latin American, n (%)

55 (30)

Others, n (%)

131 (70)

Comorbidities

Arterial hypertension, n (%)

93 (50)

Dyslipidemia, n (%)

65 (35)

Diabetes, n (%)

32 (17)

Cancer, n (%)

14 (7)

Hypothyroidism, n (%)

13 (7)

Alcohol abuse, n (%)

11 (6)

COPD, n (%)

9 (5)

Chronic liver disease, n (%)

8 (4)

Current smoker, n (%)

7 (4)

Solid organ transplant, n (%)

7 (4)

Chronic renal failure, n (%)

5 (3)

Ischemic heart diseases, n (%)

5 (3)

Clinical data

APACHE II, mean (SD)

13 (5)

Length of stay in ICU, median (IQR), days

27 (14–56)

Length of stay in hospital, median (IQR), days

54 (29–81)

Length of mechanical ventilation, median (IQR), days

14 (8–31)

Hypnosis with Midazolam n (%)

118 (63)

Days, mean (SD)

9 (8)

Hypnosis with Propofol n (%)

184 (99)

Days, mean (SD)

14 (11)

Hypnosis with Midazolam and Propofol n (%)

115 (63)

Hypnosis with Ketamine n (%)

28 (15)

Days, mean (SD)

7 (5)

Analgesia with Fentanyl n (%)

160 (86)

Days, mean (SD)

17 (16)

Analgesia with Remifentanil n (%)

47 (25)

Days, mean (SD)

10 (9)

Patients who needed paralysis, n (%)

157 (84)

Days, mean (SD)

7 (5)

Patients who needed vasopressors n (%)

155 (83)

Re-endotracheal intubation, n (%)

13 (7)

Patients who needed tracheostomy, n (%)

87 (47)

Patients who needed RRT, n (%)

15 (8)

Patients who needed support with ECMO, n (%)

5 (3)

Patients who needed support with ECCO2R, n (%)

3 (2)

Patients treated with steroids, n (%)

163 (88)

Dexamethasone, n (%)

157 (84)

Methylprednisolone, n (%)

6 (3)

Hyperactive delirium, n (%)

119 (64)

Nosocomial infection during ICU stay, n (%)

114 (61)

Patients with pulmonary embolism, n (%)

44 (24)

Patients with deep vein thrombosis, n (%)

9 (5)

Patients with ischaemic stroke, n (%)

4 (2)

Hospital discharge with home oxygen, n (%)

41 (22)

  1. BMI body mass index, COPD chronic obstructive pulmonary diseases, APACHE II acute physiology and chronic health evaluation II, SD standard deviation, ICU intensive care unit, IQR interquartile range, RRT renal replacement therapy, ECMO extracorporeal membrane oxygenation, ECCO2R extracorporeal CO2 removal.